Cencora — Aug 6, 2025 release

Healthcare Solutions segment. The Company now expects: • Revenue growth to be approximately 9 percent, from the previous range of 8 to 10 percent; ◦ U.S. Healthcare Solutions segment revenue growth to be in the range of 9 to 10 percent, from the previous range of 9 to 11 percent; ◦ International Healthcare Solutions segment revenue growth to be in the range of 6 to 7 percent, from the previous range of 3 to 4 percent; ▪ On a constant currency basis, International Healthcare Solutions segment revenue growth to be in the range of 7 to 8 percent, from the previous range of 6 to 8 percent; and • Adjusted diluted EPS to be in the range of $15.85 to $16.00, from the previous range of $15.70 to $15.95. Additional expectations now include: • Adjusted consolidated operating income growth to be in the range of 15 to 16 percent, from the previous range of 13.5 to 15.5 percent; ◦ U.S. Healthcare Solutions segment operating income growth to be in the range of 20 to 21 percent, from the previous range of 17.5 to 19.5 percent; ◦ International Healthcare Solutions segment operating income decline of approximately 6 percent, from the previous range of a decline of 1 to 4 percent; ▪ On a constant currency basis, International Healthcare Solutions segment operating income decline of approximately 5 percent, from the previous range of a decline of 3 percent to flat; and • Adjusted effective tax rate to be in the range of 20.5 to 21